CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

Modip

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 16 USDMF, 10 CEP/COS, 1 JDMF, 4 EU WC, 14 KDMF, 5 NDC API, 10 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

243 FDF Dossiers, 44 FDA Orange Book, 141 Europe, 8 Canada, 16 Australia, 7 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Minakem, 5 SPI Pharma, 5 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 3 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 21 BASF, 1 CD Formulation, 1 Clariant, 11 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 24 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 7 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 14 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 1 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 28 Solubilizers, 28 Direct Compression, 24 Granulation, 23 Controlled & Modified Release, 23 Thickeners and Stabilizers, 19 Topical, 15 Film Formers & Plasticizers, 13 Lubricants & Glidants, 12 Parenteral, 12 Co-Processed Excipients, 10 Disintegrants & Superdisintegrants, 10 Emulsifying Agents, 9 Chewable & Orodispersible Aids, 7 API Stability Enhancers, 7 Taste Masking, 6 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Coloring Agents

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 49 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

10 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
31/10/2025	Everlight Chemical	Taiwan	Everlight Chemical Industrial Corporation	219MF10301	Felodipine	2007-09-18	2023-03-23	6Floor, Chung Ting Building No. 77, Section 2, Tun Hua South Road, Taipei, Taiwan

Modip

Modip

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers

16 USDMF

10 CEP/COS

1 JDMF

4 EU WC

14 KDMF

5 NDC API

10 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

243 FDF Dossiers

44 FDA Orange Book

141 Europe

8 Canada

16 Australia

7 South Africa

27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Minakem

5 SPI Pharma

5 DKSH

1 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Kirsch Pharma

1 ACG Worldwide

5 Actylis

3 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

21 BASF

1 CD Formulation

1 Clariant

11 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

4 Ideal Cures

2 Ingredion Pharma Solutions

24 Kerry

1 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

7 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

3 Pluviaendo

1 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

15 Roquette

14 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

1 Silverline Chemicals

2 The Dow Chemical Company

2 Valens Pharmachem

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Fillers, Diluents & Binders

41 Coating Systems & Additives

28 Solubilizers

TABLET, EXTENDED RELEASE;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 2.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons